Ifp Advisors, Inc Omeros Corp Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$4.45 - $7.57 $5,971 - $10,158	1,342 New	1,342 $7,000
Q3 2021 Oct 06, 2021	SELL	$13.4 - $16.3 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$14.81 - $19.13 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$14.52 - $23.53 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$10.14 - $15.19 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$9.57 - $21.32 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$12.21 - $16.99 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$9.03 - $19.72 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$13.01 - $17.15 $26,020 - $34,300	-2,000 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	2,000	2,000 $21,000

123

25.2M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $529M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.